ClinConnect ClinConnect Logo
Search / Trial NCT03859648

BONEBRIDGE Bone Conduction Implant in Adults

Launched by MED-EL CORPORATION · Feb 28, 2019

Trial Information

Current as of May 07, 2025

Terminated

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults, 18 years of age or older at the time of implantation
  • * Conductive or mixed hearing loss, defined as:
  • Conductive hearing loss with pure-tone average (PTA) for bone conduction thresholds better than or equal to 25 dB at 500, 1000, 2000 and 3000 Hz
  • Mixed hearing loss with PTA for bone conduction thresholds better than or equal to 45dB at 500, 1000, 2000, and 3000 Hz
  • Air-bone gap greater than or equal to 30 dB at 500, 1000, 2000, and 3000 Hz
  • Ability to benefit from amplification as defined by a monosyllabic (CNC) word score of 30% correct or better
  • Bilateral BONEBRIDGE can be considered if the difference in PTA for bone conduction thresholds is 10 dB or less between the right and left ears
  • Prior experience with acoustic or bone conduction hearing aids, unless candidate is unable to wear amplification for medical reasons
  • Able to complete testing materials in English
  • CT scan indicating the patient's anatomy is adequate to enable placement of the implant
  • Ability to undergo general anesthesia
  • Appropriate motivation and expectation levels
  • Stated willingness to comply with all study procedures for the duration of the study
  • Exclusion Criteria:
  • Evidence that hearing loss is retrocochlear in origin
  • Skin or scalp condition precluding use of external audio processor
  • Suspected cognitive impairment or organic brain dysfunction

About Med El Corporation

MED-EL Corporation is a leading innovator in the field of hearing solutions, dedicated to advancing the quality of life for individuals with hearing loss through cutting-edge medical devices. Established in 1989, the company specializes in the development and manufacturing of implantable hearing systems, including cochlear implants and bone conduction devices. With a strong commitment to research and clinical excellence, MED-EL actively engages in clinical trials to evaluate the safety and efficacy of its products, ensuring that patients receive the most effective treatment options. The company's mission is to break down communication barriers and empower individuals to connect with the world around them.

Locations

London, Ontario, Canada

Philadelphia, Pennsylvania, United States

Nashville, Tennessee, United States

Columbus, Ohio, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials